 | Up a level |
Journal Article
Heidenreich, Axel, Gillessen, Silke 
ORCID: 0000-0001-5746-6555, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M., Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten and Saad, Fred
(2019).
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.
BMC Cancer, 19.
LONDON:
BMC.
ISSN 1471-2407
Morgans, Alicia K., Lehmann, Reiner, Heidenreich, Axel, Allen, Stephen, Carl, Ernst-Guenther, Wolinsky, Howard, Poschenrieder, Andreas, Mirante, Osvaldo and O'Sullivan, Joe M. (2022). Identifying patient profiles and mapping the patient journey across three countries in a large-scale, fully digital survey of patients with prostate cancer. J. Clin. Oncol., 40 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Saad, Fred, Carles, Joan ORCID: 0000-0002-9983-5934, Gillessen, Silke ORCID: 0000-0001-5746-6555, Heidenreich, Axel, Heinrich, Daniel, Gratt, Jeremy, Levy, Jeremy, Miller, Kurt, Nilsson, Sten, Petrenciuc, Oana, Tucci, Marcello, Wirth, Manfred, Federhofer, Judith and O'Sullivan, Joe M.
(2016).
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
Lancet Oncol., 17 (9).
S. 1306 - 1317.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Saad, Fred, Gillessen, Silke ORCID: 0000-0001-5746-6555, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M., Nilsson, Sten, Miller, Kurt, Wirth, Manfred, Reeves, John, Seger, Monica, Carles, Joan and Heidenreich, Axel
(2019).
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program.
Clin. Genitourin. Cancer, 17 (5).
S. 348 - 361.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 1938-0682